Galectin Therapeutics Inc
GALT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133416
In the last 90 days, Galectin Therapeutics Inc insiders filed 0 open-market purchases and 1 sale; 98 institutions reported holding it in 13F filings for Q2 2026, worth $72.2M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Galectin Therapeutics Inc changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 60 | 66 | +6 |
| Shares | 9.06M | 7.22M | −1.84M (−20.3%) |
| Value | $17.4M | $12.0M | −$5.40M (−31.0%) |
New holders (9)
Institutions that held Galectin Therapeutics Inc at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| 683 Capital Management, LLC | 111,035 | $184.3K | 0.02% |
| Solutions 4 Wealth, Ltd | 36,085 | $59.9K | 0.20% |
| Jane Street Group, LLC | 33,769 | $56.1K | 0.00% |
| Boothbay Fund Management, LLC | 23,749 | $39.4K | 0.00% |
| Inspire Advisors, LLC | 11,323 | $18.8K | 0.00% |
| Citigroup Inc | 10,650 | $17.7K | 0.00% |
| Citadel Advisors LLC | 7,010 | $11.6K | 0.00% |
| Royal Bank of Canada | 1,069 | $2.00K | 0.00% |
| UBS Group AG | 622 | $1.03K | 0.00% |
Sold out (3)
Institutions that held Galectin Therapeutics Inc at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| The PNC Financial Services Group, Inc. | 56,184 | $107.9K |
| Connor, Clark & Lunn Investment Management Ltd. | 10,049 | $19.3K |
| Farther Finance Advisors, LLC | 350 | $672 |